share_log

公告精选 | 中芯国际Q1净利同比增181.5%至4.47亿美元;四环医药澄清:私有化等新闻内容不属实

Selected Announcements | SMIC's Q1 net profit increased 181.5% year-on-year to US$447 million; Sihuan Pharmaceutical clarifies that news such as privatization is untrue

富途資訊 ·  May 13, 2022 08:29

Selection of blockbuster announcements

1、$Semiconductor Manufacturing International Corporation (00981.HK) $The profit attributable to Q1 shareholders is about US $447 million, an increase of 181.5% over the same period last year.

Semiconductor Manufacturing International Corporation announced that first-quarter revenue was 1.84 billion US dollars, up 16.6 per cent from the previous quarter and 66.9 per cent year-on-year, while first-quarter net profit was 447.2 million US dollars, down 16.2 per cent from the previous month and up 181.5 per cent from the same period last year. Due to the extension of annual repairs in some factories to the current quarter, and the short-term impact of the epidemic on capacity utilization in Shanghai, revenue is expected to grow by 1% Mel 3% in the second quarter compared with the previous quarter, with a gross profit margin of 37% Mel 39%.

2、$Hua Hong Semiconductor (01347.HK) $The board of directors has approved the proposal to issue RMB shares

Hua Hong Semiconductor announced that on May 12, 2022, the board of directors has approved the proposed RMB share issue, special mandate and related matters (including proposed amendments to the articles of association), subject to and subject to, among other things, market conditions, shareholders' approval at the EGM and necessary regulatory approvals. The company recommends that the number of RMB shares to be issued shall not exceed 433730000, that is, no more than 25 per cent of the enlarged share capital of the company after the completion of the issuance of RMB shares.

3、$clover organism-B (02197.HK) $A total of 22.673 million share options and 8.465 million restricted share units were granted

Clover Bio-B announced that on 12 May 2022, the company granted a total of 22.673 million share options and 8.465 million restricted share units to a number of eligible participants in accordance with the terms of the Post-IPO share option Scheme and the restricted share Unit Scheme respectively. The exercise price of the share option is HK $4.116 per share and is valid for 10 years.

4、$Shanghai Fosun Pharmaceutical (02196.HK) $Subsidiary FCN-159 tablets are approved to carry out clinical trials in the treatment of histiocytic tumors

Shanghai Fosun Pharmaceutical announced that recently, Shanghai Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. (hereinafter referred to as Shanghai Fosun Pharmaceutical Industry), a subsidiary of the company, received a notice from the State Drug Administration that it agreed to use FCN-159 tablets (hereinafter referred to as "the new drug") to carry out clinical trials in the treatment of histiocytic tumor. Shanghai Fosun Pharmaceutical Industry plans to conduct phase II clinical trials of this indication in Chinese mainland & Johnson when the conditions are available.

5、$Sihuan Medicine (00460.HK) $The news about privatization is not true

Sihuan Pharmaceutical issued a clarification announcement: the Board took note of articles published by several media on 12 May 2022 claiming that the Group was negotiating with potential investors for privatization and disclosed relevant valuation and privatization pricing information. The Group hereby declares that the above news is not true.

Important matters

Sihuan Medicine (00460) clarifies that news contents such as privatization are not true.

Shanghai Fosun Pharmaceutical (02196): Shanghai Fosun Pharmaceutical Industrial FCN-159 tablets are approved by drug clinical trials.

Hua Hong Semiconductor (01347) intends to issue no more than 434 million RMB shares to be listed on the Kechuang board of the Shanghai Stock Exchange.

Baolong Commercial (09909) increased its stake in 1 million shares by Chairman Xu Huafang.

Chizicheng Technology (09911) gets shareholders to increase its shareholding by 100000 shares.

Shandong Xinhua Pharmaceutical Co., Ltd. (00719) there are no changes in A shares that should be disclosed.

Changfei Optical Fiber and Optical Cable (06869): Wuhu Qidi Semiconductor Co., Ltd. has changed its name to Anhui Changfei Advanced Semiconductor Co., Ltd and become a subsidiary of the company.

CITIC (06030) buys 1 billion yuan China CITIC Bank Corporation time deposit product with an estimated annualized return of 2%

Resume trading and suspend trading

Longguang Group (03380) has suspended its trading since May 12 pending the publication of inside information.

Fusheng International (00627) has temporarily suspended its trading since May 12 pending the publication of inside information.

The reason for the temporary suspension of Baoxin Finance (01282) from 02:17 on May 12 has not been announced.

Baixin International (00574) did not announce the reason for the suspension from 01:18 on May 12.

Financial report data

Semiconductor Manufacturing International Corporation (00981) released that the profit attributable to owners in the first quarter was about US $447 million, a decrease of 16.2% compared with the previous year, an increase of 181.5% over the same period last year.

Hua Hong Semiconductor (01347) released its first-quarter results, showing a profit attributable to shareholders of US $102.9 million, up 211.4% from a year earlier.

AAC Technologies Holdings Inc. (02018) released first-quarter results, with revenue of 4.896 billion yuan, an increase of 14.1% over the same period last year.

Yue Yuen Group (00551) reports first quarter profit attributable to owners of US $88.576 million, 3.7% year-on-year increase

Manulife Financial Corporation-S (00945) released first-quarter results, realizing net income attributable to shareholders of C $3 billion

Samsonite (01910) released first-quarter profit attributable to equity holders of $16.4 million to turn a profit from a year earlier.

The property contract sales of China Olympic Garden (03883) accumulated about 9.52 billion yuan in the first four months.

Dragonair China Real Estate (06968) realized contract sales of about 4.163 billion yuan in the first four months.

Yida China (03639) April contract sales of 231 million yuan

Galaxy Entertainment (00027) released the business results in the first quarter, with an income of HK $4.1 billion, down 20% from the same period last year.

The total contract sales of China Resources Land (01109) in April was about 15.06 billion yuan, down 54.6% from the same period last year.

Vitasoy International (00345) issued a profit warning with an expected annual loss of HK $151 million to HK $172 million compared with the same period last year.

Repurchase cancellation

AIA Group Limited (01299) HK $163 million buyback 2.2434 million shares on May 12th

HSBC Holdings PLC (00005) bought back a total of 1.7472 million shares on May 12.

JD Health (06618) spent 33.5958 million Hong Kong dollars to buy back 810700 shares on May 12.

Haier Smart Home (06690) spent about 13.1272 million yuan to buy back 517100 A shares on May 12.

Pop Mart International (09992) HK $9.9977 million buyback 338200 shares on May 12th

Zhongsheng Group (00881) spent HK $9.236 million to buy back 184000 shares on May 12.

Skyworth Group (00751) spent about HK $7.7466 million to buy back 1.762 million shares on May 12.

GF Securities Co., LTD. (01776) repurchased a total of 15.24215 million A shares

HSBC Holdings PLC (00005) cancelled 1.5646 million repurchased shares on May 11.

Change of equity

Guangzhou Automobile Group (02238) gets a controlling shareholder to increase his holdings of 5.76 million H shares

Dividend dividend

Manulife Financial Corporation-S (00945) plans to pay a first-quarter dividend of C $0.33 per share on June 20.

China Unicom (00762) is expected to pay a final dividend of 0.096 yuan per share on or around June 15.

Bond bill

Far East Hongxin (03360) plans to redeem US $300 million of securities

Personnel change

Chinese traditional Medicine (00570): Chen Yinglong is appointed as Executive Director and Chairman

Air China Limited (00753): ni Jiliang was appointed Vice President

Li-Ning-Hu Expressway (00177): Cheng Xiaoguang resigned as chairman, chairman of the strategy committee of the board of directors, and director.

Edit / new

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment